135 related articles for article (PubMed ID: 20739076)
1. Measuring inappropriate medical diagnosis and treatment in survey data: The case of ADHD among school-age children.
Evans WN; Morrill MS; Parente ST
J Health Econ; 2010 Sep; 29(5):657-73. PubMed ID: 20739076
[TBL] [Abstract][Full Text] [Related]
2. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
Foy JM; Earls MF
Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
[TBL] [Abstract][Full Text] [Related]
3. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
4. Who receives a diagnosis of attention-deficit/ hyperactivity disorder in the United States elementary school population?
Schneider H; Eisenberg D
Pediatrics; 2006 Apr; 117(4):e601-9. PubMed ID: 16585277
[TBL] [Abstract][Full Text] [Related]
5. Symptoms of attention-deficit/hyperactivity disorder following traumatic brain injury in children.
Levin H; Hanten G; Max J; Li X; Swank P; Ewing-Cobbs L; Dennis M; Menefee DS; Schachar R
J Dev Behav Pediatr; 2007 Apr; 28(2):108-18. PubMed ID: 17435461
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample.
Yang P; Hsu HY; Chiou SS; Chao MC
Aust N Z J Psychiatry; 2007 Dec; 41(12):998-1004. PubMed ID: 17999272
[TBL] [Abstract][Full Text] [Related]
7. Are stimulants overprescribed? Treatment of ADHD in four U.S. communities.
Jensen PS; Kettle L; Roper MT; Sloan MT; Dulcan MK; Hoven C; Bird HR; Bauermeister JJ; Payne JD
J Am Acad Child Adolesc Psychiatry; 1999 Jul; 38(7):797-804. PubMed ID: 10405496
[TBL] [Abstract][Full Text] [Related]
8. School accountability laws and the consumption of psychostimulants.
Bokhari FA; Schneider H
J Health Econ; 2011 Mar; 30(2):355-72. PubMed ID: 21345506
[TBL] [Abstract][Full Text] [Related]
9. Attention-deficit/hyperactivity disorder with obstructive sleep apnea: a treatment outcome study.
Huang YS; Guilleminault C; Li HY; Yang CM; Wu YY; Chen NH
Sleep Med; 2007 Jan; 8(1):18-30. PubMed ID: 17157069
[TBL] [Abstract][Full Text] [Related]
10. Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database.
Winterstein AG; Gerhard T; Shuster J; Zito J; Johnson M; Liu H; Saidi A
Ann Pharmacother; 2008 Jan; 42(1):24-31. PubMed ID: 18042808
[TBL] [Abstract][Full Text] [Related]
11. National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder.
Visser SN; Lesesne CA; Perou R
Pediatrics; 2007 Feb; 119 Suppl 1():S99-106. PubMed ID: 17272592
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.
Faraone SV; Glatt SJ
J Clin Psychiatry; 2010 Jun; 71(6):754-63. PubMed ID: 20051220
[TBL] [Abstract][Full Text] [Related]
13. Children with ADHD and tic disorder and their classmates: behavioral normalization with methylphenidate.
Nolan EE; Gadow KD
J Am Acad Child Adolesc Psychiatry; 1997 May; 36(5):597-604. PubMed ID: 9136493
[TBL] [Abstract][Full Text] [Related]
14. Mental health in the United States. Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder--United States, 2003.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2005 Sep; 54(34):842-7. PubMed ID: 16138075
[TBL] [Abstract][Full Text] [Related]
15. [Better health care for children and adolescents with attention deficit hyperactivity disorder].
Klasen H; Verhulst FC
Ned Tijdschr Geneeskd; 2005 Jul; 149(31):1723-5. PubMed ID: 16114286
[TBL] [Abstract][Full Text] [Related]
16. Stimulant and psychosocial treatment of ADHD in Latino/Hispanic children.
Bauermeister JJ; Canino G; Bravo M; Ramírez R; Jensen PS; Chavez L; Martínez-Taboas A; Ribera J; Alegría M; García P
J Am Acad Child Adolesc Psychiatry; 2003 Jul; 42(7):851-5. PubMed ID: 12819445
[TBL] [Abstract][Full Text] [Related]
17. Stimulant treatment for children: a community perspective.
Angold A; Erkanli A; Egger HL; Costello EJ
J Am Acad Child Adolesc Psychiatry; 2000 Aug; 39(8):975-84; discussion 984-94. PubMed ID: 10939226
[TBL] [Abstract][Full Text] [Related]
18. Parental angst making and revisiting decisions about treatment of attention-deficit/hyperactivity disorder.
Brinkman WB; Sherman SN; Zmitrovich AR; Visscher MO; Crosby LE; Phelan KJ; Donovan EF
Pediatrics; 2009 Aug; 124(2):580-9. PubMed ID: 19651580
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study.
Biederman J; Swanson JM; Wigal SB; Kratochvil CJ; Boellner SW; Earl CQ; Jiang J; Greenhill L
Pediatrics; 2005 Dec; 116(6):e777-84. PubMed ID: 16322134
[TBL] [Abstract][Full Text] [Related]
20. Are there placebo effects in the medication treatment of children with attention-deficit hyperactivity disorder?
Waschbusch DA; Pelham WE; Waxmonsky J; Johnston C
J Dev Behav Pediatr; 2009 Apr; 30(2):158-68. PubMed ID: 19363369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
